PATH
Menu

Medical abortion—an approach that uses medication rather than surgical intervention to end a pregnancy—may be one way to help women get the safe services they need. Until recently, the two medications most widely approved for safe and effective medical abortion (mifepristone and misoprostol) were packaged and licensed separately. They are now licensed and packaged together as one product: Medabon®. This information package helps health care providers, program managers, policymakers, the media, and women understand the new product.

Corporate author(s): Concept Foundation, Ipas, PATH

Publication date: August 2009

Available materials

English

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Region: Global

See also: Reproductive healthSafe abortion

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA